Tejara Capital LTD Roivant Sciences Ltd. Transaction History
Tejara Capital LTD
- $275 Billion
- Q2 2024
A detailed history of Tejara Capital LTD transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Tejara Capital LTD holds 2,183,943 shares of ROIV stock, worth $24.9 Million. This represents 8.39% of its overall portfolio holdings.
Number of Shares
2,183,943
Previous 2,600,295
16.01%
Holding current value
$24.9 Million
Previous $27.4 Billion
15.77%
% of portfolio
8.39%
Previous 10.07%
Shares
6 transactions
Others Institutions Holding ROIV
# of Institutions
308Shares Held
497MCall Options Held
989KPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$812 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$787 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$759 Million72.99% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$403 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$334 Million0.02% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.02B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...